115 related articles for article (PubMed ID: 38663369)
1. TEAD4 activates PCSK9 to promote stomach adenocarcinoma cell stemness through fatty acid metabolism.
Xu D; Han G; Zhou X; Yong H; Jia Y; Zhao F; Shi H
Digestion; 2024 Apr; ():. PubMed ID: 38663369
[TBL] [Abstract][Full Text] [Related]
2. Transcription Factor MITF Inhibits the Transcription of CPT1B to Regulate Fatty Acid β-Oxidation and Thus Affects Stemness in Lung Adenocarcinoma Cells.
Tang W; Tang H; Xu S; Yu H; Chen Z
Pharmacology; 2024; 109(1):52-64. PubMed ID: 38016436
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor E2F3 activates CDC25B to regulate DNA damage and promote mitoxantrone resistance in stomach adenocarcinoma.
Pan X; Xu C; Cheng G; Chen Z; Liu M; Mei Y
Mol Biol Rep; 2024 Jan; 51(1):90. PubMed ID: 38194158
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor TEAD4 facilitates glycolysis and proliferation of gastric cancer cells by activating PKMYT1.
Zhan L; Wu W; Yang Q; Shen H; Liu L; Kang R
Mol Cell Probes; 2023 Dec; 72():101932. PubMed ID: 37729973
[TBL] [Abstract][Full Text] [Related]
5. OASL knockdown inhibits the progression of stomach adenocarcinoma by regulating the mTORC1 signaling pathway.
Zhao W; Yang H; Liu L; Qu X; Ding J; Yu H; Xu B; Zhao S; Xi G; Xing L; Chai J
FASEB J; 2023 Mar; 37(3):e22824. PubMed ID: 36809539
[TBL] [Abstract][Full Text] [Related]
6. FGL1 Promotes Tumor Immune Escape in Stomach Adenocarcinoma via the Notch Signaling Pathway.
Zhou Y; Liu D; Li H
Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37902887
[TBL] [Abstract][Full Text] [Related]
7. MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44.
Qi Z; Wang J; Li Y; Xu Y
J Immunol Res; 2022; 2022():5819295. PubMed ID: 35669102
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta gene as a tumour suppressor in stomach adenocarcinoma.
Li Y; Xiong JB; Jie ZG; Xiong H
Front Oncol; 2022; 12():1069875. PubMed ID: 36518312
[TBL] [Abstract][Full Text] [Related]
9. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
10. Circ_0000182 promotes cholesterol synthesis and proliferation of stomach adenocarcinoma cells by targeting miR-579-3p/SQLE axis.
Qian CJ; Zhou YX; Wu LK; Wang YC; Teng XS; Yao J
Discov Oncol; 2023 Feb; 14(1):22. PubMed ID: 36808302
[TBL] [Abstract][Full Text] [Related]
11. ClC-3/SGK1 regulatory axis enhances the olaparib-induced antitumor effect in human stomach adenocarcinoma.
Gu Z; Wang L; Yao X; Long Q; Lee K; Li J; Yue D; Yang S; Liu Y; Li N; Li Y
Cell Death Dis; 2020 Oct; 11(10):898. PubMed ID: 33093458
[TBL] [Abstract][Full Text] [Related]
12. PKNOX1 acts as a transcription factor of DHH and promotes the progression of stomach adenocarcinoma by regulating the Hedgehog signalling pathway.
Liu B; Zhao S; Liu L
Int J Immunopathol Pharmacol; 2023; 37():3946320231208833. PubMed ID: 37864517
[TBL] [Abstract][Full Text] [Related]
13. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway.
Geng H; Liu G; Hu J; Li J; Wang D; Zou S; Xu X
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396425
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TUG1 upregulates VEGFA to enhance malignant behaviors in stomach adenocarcinoma by sponging miR-29c-3p.
Jin Y; Cao J; Hu X; Cheng H
J Clin Lab Anal; 2021 Dec; 35(12):e24106. PubMed ID: 34762771
[TBL] [Abstract][Full Text] [Related]
15. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
[No Abstract] [Full Text] [Related]
16. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
17. Gene Silencing of Transcription Factor
He S; Gao K; Mao L; Bhushan S; Xiao Z
Cancer Biother Radiopharm; 2023 Mar; 38(2):132-139. PubMed ID: 32822226
[No Abstract] [Full Text] [Related]
18. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C
BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779
[TBL] [Abstract][Full Text] [Related]
19. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
[TBL] [Abstract][Full Text] [Related]
20. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mTOR Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
